BioArctic AB

Description

Develops disease-modifying treatments and research programs for neurodegenerative disorders, specifically focusing on Alzheimer’s disease and ALS for patients and healthcare providers.

Related

• BraineverDevelops novel biopharmaceutical therapies to halt neurodegenerative disease progression; used for patients with ALS, Parkinson’s disease,…
• German Center for Neurodegenerative DiseasesA research institute studying neurodegenerative diseases and developing strategies for prevention, diagnosis, care and treatment for…
• ARTHEX BIOTECH S.L.Develops RNA-based therapeutics, specifically anti-miR oligonucleotides for myotonic dystrophy and other diseases, used by researchers and…
• NeurovalensDevelops noninvasive medical neuro-technology devices for health conditions, used specifically as prescribed treatments and available to…
• TareBioDevelops vaccines intended for cancer and infectious diseases, addressing needs in oncology and infection prevention or treatment for…
• Novo Nordisk A/SBuilds medicines and treatments for people with diabetes and obesity; used by patients, healthcare professionals, and researchers for…
• Herantis Pharma OyjHerantis Pharma develops therapies for neurodegenerative diseases.
• PURPOSEFUL ΙΔΙΩΤΙΚΗ ΚΕΦΑΛΑΙΟΥΧΙΚΗ ΕΤΑΙΡΕΙΑDevelops pharmaceutical products and discovers treatments by repurposing already marketed drugs; used to address rare diseases and related…
• ALK-Abelló A/SDevelops allergy treatments and related solutions for people with respiratory allergies, serving healthcare providers and patients through…
• Faron Pharmaceuticals Ltd.Develops immunotherapies that leverage patients' immune systems for cancer treatment, serving clinical researchers and healthcare providers…
• ADmit Therapeutics S.L.ADmit Therapeutics S.L. is a frontier-technology company operating from Carretera Laurea Miro 48, Spain.
• Bavarian Nordic A/SBuilds vaccines for prevention and public health; used by travelers, healthcare providers and public health programs to protect against…